Effects of intravenous and intracoronary adenosine 5'-triphosphate as compared with adenosine on coronary flow and

A Jeremias1, S D Filardo, R J Whitbourn

  • 1Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Circulation
|January 25, 2000
PubMed

Insights

Adenosine triphosphate (ATP) is equivalent to adenosine for assessing coronary stenosis via coronary flow reserve (CFR) and fractional flow reserve (FFR). However, neither drug induces maximal hyperemia compared to complete coronary occlusion.

Area of Science:

  • Cardiovascular physiology
  • Interventional cardiology
  • Pharmacology

Background:

  • Coronary flow reserve (CFR) and fractional flow reserve (FFR) measurements require maximal hyperemia.
  • Adenosine is the standard hyperemia-inducing agent but has drawbacks like cost and tolerability.

Purpose of the Study:

  • To evaluate adenosine triphosphate (ATP) as an alternative to adenosine for inducing hyperemia.
  • To compare the efficacy of ATP and adenosine in CFR and FFR measurements.

Main Methods:

  • Equivalency testing of ATP and adenosine in canines and human stenoses.
  • Measurements of CFR and FFR using intracoronary ATP, adenosine, and coronary occlusion.
  • Dosage-response assessment for both agents.

Main Results:

  • Both ATP and adenosine significantly increased CFR and FFR, with higher doses yielding greater hyperemia.
  • ATP and adenosine demonstrated excellent linear correlation for CFR (R=0.934) and FFR (R=0.985).
  • Hyperemic response to ATP and adenosine was less than that achieved by coronary occlusion.

Conclusions:

  • Increased dosages of ATP and adenosine enhance coronary hyperemia beyond standard clinical recommendations.
  • ATP is therapeutically equivalent to adenosine for CFR and FFR assessment.
  • Neither pharmacological agent achieved maximal hyperemia; coronary occlusion provided a superior hyperemic response.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...